MedPath

The efficacy of recombinant thrombomodulin in a patient with cholangitis with DIC

Phase 2
Conditions
Cholangitis with DIC
Registration Number
JPRN-UMIN000018607
Lead Sponsor
Yokohama city university, Depertment of gastroenterologicl surgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
250
Inclusion Criteria

Not provided

Exclusion Criteria

1. The patients with hemorrhagic lesion. 2. The patients with allergy in rTM. 3. the pregnancy patients 4. Non imformed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of DIC, DIC resolution rates
Secondary Outcome Measures
NameTimeMethod
survival rate in 28 days
© Copyright 2025. All Rights Reserved by MedPath